Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2

被引：279

作者：

Amary, M. Fernanda ^{[1
]}

Damato, Stephen ^{[1
]}

Halai, Dina ^{[1
]}

Eskandarpour, Malihe ^{[2
]}

Berisha, Fitim ^{[1
]}

Bonar, Fiona ^{[3
]}

McCarthy, Stan ^{[4
]}

Fantin, Valeria R. ^{[5
]}

Straley, Kimberly S. ^{[5
]}

Lobo, Samira ^{[1
]}

Aston, Will ^{[6
]}

Green, Claire L. ^{[2
]}

Gale, Rosemary E. ^{[2
]}

Tirabosco, Roberto ^{[1
]}

Futreal, Andrew ^{[7
]}

Campbell, Peter ^{[7
]}

Presneau, Nadege ^{[2
]}

Flanagan, Adrienne M. ^{[1
,2
]}

机构：

[1] Royal Natl Orthopaed Hosp Natl Hlth Serv Trust, Histopathol Unit, Stanmore, Middx, England

[2] Univ Coll London Canc Inst, London, England

[3] Douglass Hanly Moir Pathol, Sydney, NSW, Australia

[4] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia

[5] Agios Pharmaceut, Cambridge, MA USA

[6] Royal Natl Orthopaed Hosp Natl Hlth Serv Trust, Bone Tumour Unit, Stanmore, Middx, England

[7] Wellcome Trust Sanger Inst, Cambridge, England

来源：

NATURE GENETICS | 2011年 / 43卷 / 12期

基金：

英国惠康基金;

关键词：

ENCHONDROMATOSIS; GLIOMA;

D O I：

10.1038/ng.994

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Ollier disease and Maffucci syndrome are characterized by multiple central cartilaginous tumors that are accompanied by soft tissue hemangiomas in Maffucci syndrome. We show that in 37 of 40 individuals with these syndromes, at least one tumor has a mutation in isocitrate dehydrogenase 1 (IDH1) or in IDH2, 65% of which result in a R132C substitution in the protein. In 18 of 19 individuals with more than one tumor analyzed, all tumors from a given individual shared the same IDH1 mutation affecting Arg132. In 2 of 12 subjects, a low level of mutated DNA was identified in non-neoplastic tissue. The levels of the metabolite 2HG were measured in a series of central cartilaginous and vascular tumors, including samples from syndromic and nonsyndromic subjects, and these levels correlated strongly with the presence of IDH1 mutations. The findings are compatible with a model in which IDH1 or IDH2 mutations represent early post-zygotic occurrences in individuals with these syndromes.

引用

页码：1262 / U129

页数：5

共 11 条

[1] IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours [J].

Amary, M. Fernanda ;

Bacsi, Krisztian ;

Maggiani, Francesca ;

Damato, Stephen ;

Halai, Dina ;

Berisha, Fitim ;

Pollock, Robin ;

O'Donnell, Paul ;

Grigoriadis, Anita ;

Diss, Tim ;

Eskandarpour, Malihe ;

Presneau, Nadege ;

Hogendoorn, Pancras C. W. ;

Futreal, Andrew ;

Tirabosco, Roberto ;

Flanagan, Adrienne M. .

JOURNAL OF PATHOLOGY, 2011, 224 (03) :334-343

[2] IDH mutations in glioma and acute myeloid leukemia [J].

Dang, Lenny ;

Jin, Shengfang ;

Su, Shinsan M. .

TRENDS IN MOLECULAR MEDICINE, 2010, 16 (09) :387-397

[3] Cancer-associated IDH1 mutations produce 2-hydroxyglutarate [J].

Dang, Lenny ;

White, David W. ;

Gross, Stefan ;

Bennett, Bryson D. ;

Bittinger, Mark A. ;

Driggers, Edward M. ;

Fantin, Valeria R. ;

Jang, Hyun Gyung ;

Jin, Shengfang ;

Keenan, Marie C. ;

Marks, Kevin M. ;

Prins, Robert M. ;

Ward, Patrick S. ;

Yen, Katharine E. ;

Liau, Linda M. ;

Rabinowitz, Joshua D. ;

Cantley, Lewis C. ;

Thompson, Craig B. ;

Heiden, Matthew G. Vander ;

Su, Shinsan M. .

NATURE, 2009, 462 (7274) :739-U52

[4] Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation [J].

Figueroa, Maria E. ;

Abdel-Wahab, Omar ;

Lu, Chao ;

Ward, Patrick S. ;

Patel, Jay ;

Shih, Alan ;

Li, Yushan ;

Bhagwat, Neha ;

Vasanthakumar, Aparna ;

Fernandez, Hugo F. ;

Tallman, Martin S. ;

Sun, Zhuoxin ;

Wolniak, Kristy ;

Peeters, Justine K. ;

Liu, Wei ;

Choe, Sung E. ;

Fantin, Valeria R. ;

Paietta, Elisabeth ;

Lowenberg, Bob ;

Licht, Jonathan D. ;

Godley, Lucy A. ;

Delwel, Ruud ;

Valk, Peter J. M. ;

Thompson, Craig B. ;

Levine, Ross L. ;

Melnick, An .

CANCER CELL, 2010, 18 (06) :553-567

[5] A mutant PTH/PTHrP type I receptor in enchondromatosis [J].

Hopyan, S ;

Gokgoz, N ;

Poon, R ;

Gensure, RC ;

Yu, CY ;

Cole, WG ;

Bell, RS ;

Jüppner, H ;

Andrulis, IL ;

Wunder, JS ;

Alman, BA .

NATURE GENETICS, 2002, 30 (03) :306-310

[6] Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma [J].

Krell, Daniel ;

Assoku, Mawuelikem ;

Galloway, Malcolm ;

Mulholland, Paul ;

Tomlinson, Ian ;

Bardella, Chiara .

PLOS ONE, 2011, 6 (05)

[7] Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma [J].

Noushmehr, Houtan ;

Weisenberger, Daniel J. ;

Diefes, Kristin ;

Phillips, Heidi S. ;

Pujara, Kanan ;

Berman, Benjamin P. ;

Pan, Fei ;

Pelloski, Christopher E. ;

Sulman, Erik P. ;

Bhat, Krishna P. ;

Verhaak, Roel G. W. ;

Hoadley, Katherine A. ;

Hayes, D. Neil ;

Perou, Charles M. ;

Schmidt, Heather K. ;

Ding, Li ;

Wilson, Richard K. ;

Van Den Berg, David ;

Shen, Hui ;

Bengtsson, Henrik ;

Neuvial, Pierre ;

Cope, Leslie M. ;

Buckley, Jonathan ;

Herman, James G. ;

Baylin, Stephen B. ;

Laird, Peter W. ;

Aldape, Kenneth .

CANCER CELL, 2010, 17 (05) :510-522

[8] Genome-wide analysis of Ollier disease: Is it all in the genes? [J].

Pansuriya, Twinkal C. ;

Oosting, Jan ;

Krenacs, Tibor ;

Taminiau, Antonie H. M. ;

Verdegaal, Suzan H. M. ;

Sangiorgi, Luca ;

Sciot, Raf ;

Hogendoorn, Pancras C. W. ;

Szuhai, Karoly ;

Bovee, Judith V. M. G. .

ORPHANET JOURNAL OF RARE DISEASES, 2011, 6

[9]

Pansuriya TC, 2010, INT J CLIN EXP PATHO, V3, P557

[10] Value and Limitations of Immunohistochemistry and Gene Sequencing for Detection of the IDH1-R132H Mutation in Diffuse Glioma Biopsy Specimens [J].

Preusser, Matthias ;

Woehrer, Adelheid ;

Stary, Susanne ;

Hoeftberger, Romana ;

Streubel, Berthold ;

Hainfellner, Johannes A. .

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2011, 70 (08) :715-723

← 1 2 →